Promoter holding
64.27%
ML
Medicaps Limited - Due diligence report
A 360° intelligence report on Medicaps Limited: trust score, financial health, credit view, compliance, directors, growth and distress signa…
Full Due-Diligence Report + Documents
- Unlock all financial figures & 5-year trends
- Full trust, health & credit-risk scores
- Director details, charges & MCA documents
₹700
₹449
Save ₹251
excl. GST
Or from ₹279/report with credits
View credit packages
Company Credits – Starter
- One credit unlocks this full due-diligence report
- Use across any company’s report, anytime
- Credits valid for 12 months
Choose your own credit amount
View credit packages
Medicaps Limited — 360° Intelligence Report
Generated from MCA filings & public records86/100
Trust Score
Low Risk
Medicaps Limited is assessed as Low Risk with a Trust Score of 86/100. Medicaps Limited is an active public limited indian non-government company incorporated in 1983, operating in the Pharma sector. Reported revenue has declined across its recent filed years. It reported a loss in its latest filed year. Based on MCA filings and public records, it currently shows a low compliance risk and moderate financial risk profile.
Report generated on 16 Jul 2026 from the latest processed filings. Medicaps Limited snapshot & full profile →
Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.
02
Score Card
Higher is safer · rule-based & explainableTrust ScoreLow Risk
86/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreLow Risk
93/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreModerate
65/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreModerate
70/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreLow Risk
90/100
Board strength, DIN status, churn and network.
Growth ScoreCaution Indicated
40/100
Revenue, profit, asset and hiring momentum.
Distress ScoreLow Risk
90/100
Early-warning signals - higher means fewer warnings.
03
Financial Intelligence Dashboard
Consolidated · 5 filed year(s)Unlock the full 5-year financial dashboard with charts and year-wise figures.
Get full accessScores and observations on this page are already computed from the real filings - only the underlying figures are locked.
04
Credit & Compliance Intelligence
Why the scores are what they are
Credit Risk Score: 70/100 Moderate
- Moderate gearing (D/E 38%).
- Working-capital cover adequate.
Charges position: 3 open (20.00 Lakh) · 3 satisfied (2.22 cr).
Banking relationships (from registered charges)
| Lender | Charges | Amount |
|---|---|---|
| I.D.B.I. Bank Ltd. | 1 | 48.0 cr |
| M.P. Audyogik Vikas Nigam Ltd. | 1 | 48.0 cr |
| Bank Of Baroda | 3 | 48.0 cr |
| Axis Bank Limited | 1 | 48.0 cr |
Compliance Score: 93/100 Low Risk
- Company status is Active as per MCA.
- Annual filings current (balance sheet Mar 2025).
- Litigation present in 1 court forum(s).
- 1 active GST registration(s).
Legal cases on record (1)
05
Director Intelligence
Stability score: 90/100| Name | DIN / PAN | Designation | Appointed | Tenure | DIN status |
|---|---|---|---|---|---|
| ASHOK AGRAWAL OMPRAKASH | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| GAJENDRA SINGH | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| DHARMENDRA SOLANKI | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| Hemant Sethi | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| RAMESH CHANDRA MITTAL | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| KUSUM MITTAL | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| ABHISHEK KUMAR | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| ALOK K GARG | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| Abhishek Jain | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
- 9 directors on the board.
- No disqualified or deactivated DINs.
- 1 director exit(s) in the last 3 years.
- Average tenure above 5 years.
Director & KMP remuneration (FY 2025)
| Name | Designation | Total remuneration |
|---|---|---|
| A K Sharma | Managing Director | 2.4 cr |
| R Mehta | Whole-time Director | 1.6 cr |
| S Iyer | CFO | 95.0 L |
Remuneration is disclosed in the latest annual return. Unlock full report
06
Ownership & Group Intelligence
As per FY 2025 annual returnPublic / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
-
Subsidiaries
1
Group entities
1
Capital events
0 allotment(s) · 18 transfer(s)
Promoters hold a majority stake - exact percentages are part of the full report.
| Group entity | Relationship | % held |
|---|---|---|
| Medgel Private Limited | Subsidiary Company | 74.00% |
Key managerial personnel: Hemant Sethi (CFO) · ALOK K GARG (Managing Director)
Full shareholding pattern, group structure & capital events →
07
Risk Intelligence Center
Growth 40 · Distress 90
Growth signals & trust indicators
Operating for 42+ years.
Active EPFO - real payroll on record.
Active GST registration(s).
Distress signals & risk flags
3 open charge(s) registered - assets are encumbered.
1 court case(s) on record - see the legal section for details.
08
Stakeholder Verdicts
Vendor · Banker · InvestorVendor due diligence90/100
Favourable indicators
Suitability as a supplier / customer counterparty.
- Statutory record is clean.
- No distress signals on file.
- Financial filings available for verification.
Banker assessment74/100
Favourable lending indicators
Indicative lending comfort for banks, NBFCs and trade credit.
- Debt capacity assessed from filed statements.
- 3 open charge(s) of 20.00 Lakh already registered.
- Compliance record supports lending.
Investor view60/100
Mixed indicators
Growth quality and scalability through an investor lens.
- No clear growth signals in the filed years.
- Margin and return trends computable from filings.
- Management team looks stable.
09
MCA Filings & Events Timeline
Latest 15 events18 Sep 2025
Last AGM held
Annual general meeting
31 Mar 2025
Latest balance sheet
Filed with ROC
28 Sep 2023
Director ceased
GAJENDRA SINGH
11 Aug 2023
Director appointed
GAJENDRA SINGH (Director)
28 Sep 2022
Director ceased
AKSHIT GARG
Director ceased
SOURABH KUMAR SHRIVAS
31 Mar 2022
Share transfer (FY 2022)
400.00000000 shares to VILAYET CALLISTUS HENRIQUES
10 Feb 2022
Director appointed
ABHISHEK KUMAR (Company Secretary)
Director appointed
Abhishek Jain (Company Secretary)
28 Sep 2021
Director ceased
DHARMENDRA SOLANKI
27 Sep 2021
Director ceased
ALOK K GARG
23 Mar 2021
Charge satisfied
Axis Bank Limited
05 Feb 2021
Director appointed
DHARMENDRA SOLANKI (Director)
20 Nov 2020
Director ceased
SHAMSHER SINGH
31 Mar 2020
Share transfer (FY 2020)
600.00000000 shares to SUNIL SOJATIA
10
Key Observations
Auto-generated from the data aboveRevenue declined 1.42 over the last 4 financial year(s).
Net profit margin moved from 2.1x to 24%.
Debt-to-equity stands at 0.86 - manageable leverage.
Net worth is positive.
Compliance record is strong - status, filings and flags are clean.
9 active director(s) / partner(s); board looks stable and experienced.
1 active GST registration(s) indicate ongoing business operations.
Operates a group structure with 1 subsidiary(ies) - assess on a consolidated basis.
EPFO-registered employer - verifiable payroll history exists.
Promoters hold a majority stake as per the FY 2025 annual return.
Director / KMP remuneration is disclosed in the latest annual return - exact figures available in the full report.
| Company | CIN | Location |
|---|---|---|
| Ridhi Synthetics Limited | L51900MH1981PLC025265 | Mumbai, Maharashtra, India |
| Krishnaventures | L45400MH1981PLC025151 | Mumbai, Maharashtra, India |
| Rose Building Solutions Limited | U70109DL2013PLC257303 | New Delhi, Delhi, India |
| Black Gold Developers Private Limited | U45202MH2008PTC184505 | Mumbai, Maharashtra, India |
| Rril Limited | L17121MH1991PLC257750 | Mumbai, Maharashtra, India |
| Kemp And Company Limited | L24239MH1982PLC000047 | Mumbai, Maharashtra, India |
| S V Global Mill | L17100TN2007PLC065226 | Chennai, Tamil Nadu, India |
| Values Tax | U74900TG2011PTC076965 | Hyderabad, Telangana, India |
12
Who Uses This Report
CA · CS · Banker · Investor · VendorChartered Accountants (CA)
Verify Medicaps Limited before audits and certifications: compliance score 93/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.
Company Secretaries (CS)
Track statutory health of Medicaps Limited: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.
Bankers & NBFCs
Current banker verdict: Favourable lending indicators. Credit risk score 70/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.
Investors & Analysts
Investor view: Mixed indicators. Growth score 40/100, margin trends, ownership structure and peer set for Medicaps Limited - screening before a deeper diligence.
Vendors & Procurement Teams
Vendor verdict: Favourable indicators. Trust score 86/100, distress signals and MSME payment-delay disclosures - know whether Medicaps Limited pays its suppliers before you extend credit terms.
Lawyers & Compliance Teams
Litigation footprint (1 case(s) on record), regulatory flags, charge documents trail and director networks for Medicaps Limited - groundwork for KYC, onboarding and disputes.
13
Frequently Asked Questions
Is Medicaps Limited an active company?
Medicaps Limited has MCA status “Active” with a compliance score of 93/100 (Low Risk).
Is Medicaps Limited financially healthy?
Medicaps Limited has a Financial Health Score of 65/100 (Moderate) based on its filed financial statements.
Should I do business with Medicaps Limited?
Its overall Trust Score is 86/100 (Low Risk). Vendor verdict: Favourable indicators. Review the risk flags in the Risk Intelligence Center before deciding.
Who controls Medicaps Limited?
Promoters hold a majority stake - exact percentages are in the full report. 9 active director(s) are on record.
Does Medicaps Limited have loans or charges against its assets?
3 open charge(s) are registered against its assets, and 3 earlier charge(s) stand satisfied.
Is Medicaps Limited up to date with its ROC filings?
Annual filings current (balance sheet Mar 2025). Overall compliance score: 93/100 (Low Risk).
Is it risky to lend to Medicaps Limited?
Its Credit Risk Score is 70/100 (Moderate). Banker verdict: Favourable lending indicators.
Disclaimer: This report is generated automatically from MCA filings and public records as available
in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the
underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are
not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice.
Verify from official sources and consult a qualified professional before any business, lending or investment decision.
If you represent this company and believe any information is inaccurate or outdated,
report it here and we will review promptly.
